On July 30, ASYMCHEM (06821) fell 5.07% in regular trading, trading at HK$110.2/share, with turnover of HK$22.15 million.
On the news front, multiple major institutional shareholders have continuously reduced their positions in ASYMCHEM H-shares in recent weeks. Schroders PLC sold 80,700 shares on July 2 and 208,000 shares on July 15. Norges Bank cumulatively reduced over 610,000 shares across July 6, 7, and 14, with its stake declining from 9.58% to 7.40%. Although JPMorgan added 143,800 shares on July 7 and 185,950 shares on July 16, and China Southern Asset Management increased 109,700 shares on July 20, overall institutional capital has shown net outflows. Additionally, the company's margin trading balance has been shrinking recently, with deleveraging in margin positions intensifying selling pressure. The broader pharmaceuticals sector also remains under pressure, with CSPC Pharma down 2.17% and Hansoh Pharma down 1.13%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments